Ocumension Therapeutics
Reporting Owner SEC Filing List

CIK: 0001840315
FormFilerSubject CompanyFiling AgentDateActions
4Statement of changes in beneficial owner...Ocumension Therapeutics01/16/2024
4Statement of changes in beneficial owner...Eyepoint Pharmaceuticals, Inc.Ocumension Therapeutics /fa01/16/2024
144Filing for proposed sale of securities u...Ocumension Therapeutics01/11/2024
144Filing for proposed sale of securities u...Eyepoint Pharmaceuticals, Inc.Ocumension Therapeutics /fa01/11/2024
4Statement of changes in beneficial owner...Ocumension Therapeutics12/07/2023
4Statement of changes in beneficial owner...Eyepoint Pharmaceuticals, Inc.Ocumension Therapeutics /fa12/07/2023
144Filing for proposed sale of securities u...Ocumension Therapeutics12/05/2023
144Filing for proposed sale of securities u...Eyepoint Pharmaceuticals, Inc.Ocumension Therapeutics /fa12/05/2023
144Filing for proposed sale of securities u...Ocumension TherapeuticsMa Yimeng /fa05/26/2023
144Filing for proposed sale of securities u...Eyepoint Pharmaceuticals, Inc.Ma Yimeng /fa05/26/2023
Load More

Ocumension Therapeutics 's Ownership Transactions

IssuerFiling
Date
Transaction
Date
Transaction
Type
SharesPriceTotal AmtShares Owned